Dianthus Therapeutics Inc. (DNTH)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
4,952,989,000
EV to revenue ratio (TTM)
2,277.58
EV to ebitda
-7.35
Financial Performance
Revenue (TTM)
1,904,000
Gross profit (TTM)
1,904,000
EBITDA
-217,720,992
Profitability
Operating margin (TTM)
-8,079.00%
Profit margin
0.00%
Return on assets (TTM)
-17.70%
Return on equity (TTM)
-26.10%
Per Share Metrics
Revenue per share (TTM)
0.04
EPS
-4.24
Diluted EPS (TTM)
-4.24
Book value
21.39
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
2,542.38
Price to book ratio (TTM)
4.456
Growth
Quarterly earnings growth (YoY)
294.30%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
14
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.063